KEN HORNE

Managing Partner
AN Venture Partners

Ken Horne is an experienced healthcare investor, entrepreneur and executive with over two decades of professional success. He currently serves as the Managing Partner of AN Ventures, a Japan focused biotech fund. Previously he was the chairperson of RDiscovery, Remiges Ventures’ company creation entity. In this role, he has helped start and invest in Capacity Bio, Typewriter Therapeutics, and Viage Therapeutics as President or CEO. Previously as an entrepreneur, he co-founded or led Aline Aesthetics (acquired by Allergan), Symic Bio (acquired by Nordic Bio), and Teon Therapeutics. Before that, he was a founding member of TauTona Group, an early-stage life science venture capital fund backed by Stanford Management Company and other top LPs. He started his career working for The Foundry, a preeminent medtech incubator, and he was an early or founding employee at eValve (acquired by Abbott), Cierra (acquired by Terumo) and others.

Ken has a BS and MS degree from Stanford University in mechanical engineering, and as a Kauffman Fellow (Class 17) was the Jeff Timmons Leadership Awardee.